Pamela Savoy has been appointed director of business development and CMC Services at DS InPharmatics (DSI). Ms. Savoy is responsible for developing client relationships and providing leadership to achieve DSI’s business development objectives. She has an extensive pharmaceutical background in oversight of technology transfer programs from early stage drug development to global regulatory submission and commercial launch.

“Pam is a truly talented individual with over 20 years of experience in the pharmaceutical industry. She will be a tremendous asset to the growing list of DSI clientele across the globe. With Pam’s extensive background in innovation and brand management, we are confident her leadership will fuel strategic growth initiatives,” said Edward Narke, regulatory managing director at DSI. “We’re pleased to have Pam on board and look forward to the knowledge that she’ll bring to this growing company.”

Prior to joining DSI, Ms. Savoy held positions in business development and project management at Ben Venue Laboratories and clinical research at Roche Vitamins and Fine Chemicals.